Quality Metrics May Reduce FDA Inspections For Pharma Cos.
Law360, New York (August 11, 2015, 10:32 AM EDT) -- Quality metrics are utilized throughout the pharmaceutical industry to monitor quality control systems and processes and to drive continuous improvement efforts in drug development and manufacturing. The U.S. Food and Drug Administration, through a recently-published draft guidance and its corresponding Federal Register notice, is making good on its decade-old promise to create a system in which pharmaceutical manufacturers consistently and reliably produce "high-quality drug products without extensive regulatory oversight." This guidance offers transparency to industry by painting a clear picture of what the agency is thinking with regard to the use of certain quality metrics for risk-based oversight. Entities that work to internalize this guidance and produce timely, thoughtful reports to the agency that demonstrate highly controlled manufacturing and a robust quality measurement system should see positive results: less frequent agency inspections and greater ability to self-regulate....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.